Brief: Lytix Biopharma Says Raising Up To Nok 55 Mln
April 9 (Reuters) - Lytix Biopharma AS LYTIX.OL :
* LYTIX BIOPHARMA RAISING UP TO NOK 55 MILLION WITH STRONG
SUPPORT
FROM EXISTING SHAREHOLDERS - SEVERAL KEY MILESTONES COMING UP
WITH LARGE COMMERCIAL POTENTIAL
Source text for Eikon: ID:nObiYn92ta
Further company coverage: LYTIX.OL
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lytix Biopharma AS
See all newsBrief: Lytix Biopharma Q3 Loss Widens To NOK 23.3 Mln
Brief: Lytix Biopharma Announces Interim Data On Neoadjuvant Treatment Of Melanoma
Brief: Lytix Biopharma Q1 Operating Loss Narrows To NOK 13.4 Mln
Brief: Lytix Biopharma Q4 Total Operating Income Nok 377,000
Brief: Lytix Biopharma Gets Notice Of Allowance For US Patent Application For Ltx-315 Clinical Program